Why is my sales team missing target?

If your sales team is missing target, don’t start with training, more activity or motivation. Start with the maths.

A sales team can miss target because it lacks enough qualified pipeline, converts too little of it, wins deals that are too small, or takes too long to close them.

Those numbers tell you where to investigate. They don’t necessarily tell you why the problem exists.

Missing target is the symptom. Diagnosis comes next.

Start with four commercial signals.

Four numbers carry most of the diagnostic weight when a team is behind: pipeline, win rate, deal value and sales cycle. They do not explain the whole sales system, and they do not explain themselves. What they do is turn a vague problem — we are behind — into a specific one: we do not have enough credible opportunity to cover the gap.

Work through them in order. The first signal that fails is where the investigation starts, and it is usually the one that makes the others look worse than they are.

If your sales team is missing target, check these four numbers first.

This is the first check because nothing downstream can compensate for a shortfall here. Look at the qualified pipeline standing against the remaining target, not total CRM value.

• Qualified pipeline against the revenue still to be closed
• Ageing opportunities that have not moved for a quarter
• Weekly pipeline creation, by seller and in total
• Concentration: how much of the number depends on a handful of deals
• Realistic coverage based on the win rate you actually achieve

You need enough credible pipeline, not simply enough CRM value.

If pipeline is genuinely short, most other interventions are premature. If it is sufficient, the problem is further down the chain.

A team with adequate pipeline and a weak win rate has a conversion problem, not a volume problem. Look at the number in cuts rather than in aggregate:

• Overall win rate against the rate the business is planned on
• Win rate by seller, and how wide the spread is
• By segment, source, and product or service
• Stage-to-stage conversion, to find where deals actually die
• Documented loss reasons, including losses to no decision

A weak win rate tells you where to investigate. It may be caused by qualification, discovery, account selection, stakeholder access, value articulation, competitive positioning, pricing, capability or manager involvement. Those are very different problems with very different fixes.

The number tells you where to look. It doesn’t automatically tell you why.

A team can be busy, disciplined and converting well, and still miss target because the deals are too small. Look at average deal value, how far it varies between sellers, and whether it reflects the size of the accounts being worked.

• Average deal value, and the variation across the team
• Whether deal size matches customer or account size
• How well sellers identify wider need beyond the initial request
• Cross-sell and expansion within existing accounts
• Any tendency to default to smaller, easier, faster wins

In a programme previously led by our founder, one team increased average deal value by approximately 72% while completing around 17% fewer transactions.

Performance improved because the team shifted towards larger, better-qualified opportunities. They didn’t simply need more activity. They needed better business.

See the full sales performance case study→

Cycle length is where forecast slippage usually hides. The question is not whether the cycle is long, but whether it is longer than it needs to be.

• Average cycle length, and how it has moved over the year
• Stage ageing: where opportunities sit longest
• Time between meaningful customer interactions
• Slipped opportunities and repeatedly moved close dates
• Proposal delays and unclear next steps
• Differences between sellers on comparable deals

A four-week cycle isn’t inherently better than a four-month one. The right question is whether the cycle is appropriate for what you sell and whether avoidable delays are trapping revenue.

Where cycles stretch, the cause is often weak qualification, no access to the real decision makers, an unclear decision process, commercial or procurement delays, inconsistent follow-up, or opportunities that should not still be open at all.

The signal identifies the area. Diagnosis identifies the cause.

Four signals, four questions.

The number tells you where to look. It doesn’t tell you why.

Finding the weakest commercial signal is only level one of the diagnosis. It narrows the search. Level two is identifying what is actually causing it, because two teams with the same weak win rate can need entirely different interventions.

Candidate causes are usually somewhere in qualification, targeting, capability, manager coaching, opportunity strategy, sales process, CRM adoption, reinforcement, execution, proposition or pricing. Most of these leave evidence, in the data, in the CRM, in call and meeting behaviour, and in how managers run their weekly rhythm.

Only after both levels are understood should an intervention be chosen.

Don’t prescribe before you diagnose.

When a team is behind, the pressure to act is immediate, and the available actions are familiar: more calls, more emails, more pipeline, more training, a new methodology, tighter accountability, new tools, extra coaching.

All of these may be right. But only if the evidence supports them.

• If pipeline is sufficient but win rate is poor, more activity may create more opportunities to lose.
• If the issue is weak qualification, closing training may not solve it.
• If the issue is territory design, training will not fix it.
• If the issue is capability, training may be exactly the right intervention.

The intervention should fit the constraint.

None of this is an argument against sales training. Well-designed training changes performance when there is a genuine capability gap to close. The waste comes from buying it as a default response to a number, without first establishing what the number is telling you.

Look at managers, not just sellers.

Seller performance is heavily shaped by the manager above them. Managers influence opportunity quality, coaching, forecast discipline, prioritisation, accountability, deal strategy and whether anything from a training programme is still happening three months later.

The pipeline review is where this is easiest to see. If the review only ever asks “what are you closing this month?”, it becomes a reporting meeting: the manager collects numbers and the deal does not move.

Better questions change the outcome. “What is stopping this opportunity progressing?” and “what evidence tells us this deal is genuinely qualified?” put the conversation on the constraint rather than the forecast.

Team averages can hide the real problem.

A 30% average win rate could mean everyone is converting at around 30%. It could also mean top sellers are at 50%, a middle group at 25%, and the weakest sellers at 10%. Those are different performance problems, and they need different responses.

So analyse in layers: team, then seller, then opportunity, then behaviour.

• Where is performance concentrated?
• Who consistently outperforms, on comparable opportunities?
• What are they doing differently, specifically?
• Where does the gap first appear — targeting, qualification, progression or close?

The answer usually points towards a targeted intervention with a small number of people, rather than a team-wide programme that treats strong and weak performers identically.

Nine questions for your next sales leadership meeting.

1. 1Target. What revenue gap are we actually trying to close?
2. 2Pipeline. Do we have enough genuinely qualified opportunity?
3. 3Win rate. Are we converting it at the rate we should?
4. 4Deal value. Are the opportunities we’re winning valuable enough?
5. 5Sales cycle. Is revenue moving quickly enough?
6. 6Distribution. Is the problem team-wide or concentrated?
7. 7Root cause. What evidence explains the weakest signal?
8. 8Intervention. What is the smallest targeted change most likely to move it?
9. 9Measurement. What number and behaviour will tell us whether it worked?

What this can look like in practice.

Two sales teams. Same visible problem: both were missing target.

After targeted intervention, combined target attainment moved from 63.7% to 110.8%. But the important point wasn’t simply the uplift. The teams improved for different reasons.

One improved broadly across the commercial scorecard. The other increased average deal value by approximately 72% while transaction volume fell around 17%.

The answer wasn’t more activity. It was better business.

Read the full commercial impact case study→

If your sales team is missing target, start with diagnosis.

Pressure creates a natural desire to act quickly. But fast action against the wrong problem is still the wrong action, and it costs a quarter you do not get back.

Before changing compensation, training, activity targets, methodology, tools or sellers, understand the constraint. Then find where performance is breaking, understand why, choose the intervention, and measure whether it worked.

Diagnose → Prioritise → Improve → Measure.

Frequently asked questions.

James King

Founder, Revenue Performance Partners

James works across sales performance, enablement and commercial operations, helping organisations diagnose performance gaps and turn them into measurable improvement.

More about James→